Delivery Order SPE2DB22D2007-SPE2DB25FJ0TR
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The total ceiling value of the contract is $8,333.90, and it has a period of performance through December 17, 2024. The contract is a firm-fixed price delivery order and does not...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.23 firm fixed-price contract is for the supply of 90-count bottles of 16 mg Candesartan Cilexetil tablets, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,022.52 firm fixed-price contract is for the delivery of candesartan cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 12, 2022. The delivery order was issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $38,542.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, which are used to treat high blood pressure and heart failure. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 8 mg tablets, a medication used for the treatment of hypertension and heart failure. The contract has a ceiling value of $3,340.44 and an ultimate completion date of March 12, 2025. It is a Firm Fixed Price contract, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.19 delivery order is for Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of October 28, 2024 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Candesartan Cilexetil 16 mg tablets, a pharmaceutical product used in the treatment of hypertension and heart failure. The contract has a ceiling value of $11,747.16 and a period of performance through May 13, 2025. This contract is not designated as a set-aside and was awarded on...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has a ceiling value of $1,967.43 and runs through April 2, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. The award is associated with...
This is a federal delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,412.76 firm-fixed-price contract is for the delivery of 90 tablets of 16 mg Candesartan Cilexetil, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FC0B4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.69 delivery order contract is for the supply of 4,568,075,934 units of Candesartan Cilexetil 32 mg tablets, a medication used to treat high blood pressure and heart failure. The contract is a firm fixed-price delivery order, with an ultimate completion date of April...